Pharmaceutical composition containing trandolapril taste masking composition

The technology of trandolapril and composition is applied in the field of medicine containing trandolapril taste-masking composition, can solve the problems of limited disintegration rate, slow metabolism, poor taste, etc., and achieves strong medical and health care effect, good taste, Good for masking bitterness

Inactive Publication Date: 2017-02-22
ABA CHEM SHANGHAI
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But the pharmaceutical composition containing the trandolapril taste-masking composition of the present invention has certain shortcomings: 1. Aspartame in the trandolapril taste-masking composition in the formula is an artificial sweetener, and its sweetness is high Due to natural sweeteners, it changes the tas

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition containing trandolapril taste masking composition
  • Pharmaceutical composition containing trandolapril taste masking composition
  • Pharmaceutical composition containing trandolapril taste masking composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] This embodiment contains the pharmaceutical composition of trandolapril taste-masking composition, which is composed of the following raw materials in parts by weight: 60 parts of trandolapril taste-masking composition, pregelatinized starch 1500 filler 20 (4 parts of corn starch, 12 parts of potato starch and 4 parts of rice starch), 9 parts of polyvinylpyrrolidone binder, 8 parts of disintegrant and 6 parts of lubricant; wherein, the taste-masking composition of trandolapril consists of 20.13 Parts by weight of mannitol, 20.13 parts by weight of gelatin, 0.29 parts by weight of disodium glycyrrhizinate and 1.45 parts by weight of trandolapril are mixed; 4.52 parts of croscarmellose sodium and 3.48 parts of crospovidone; the lubricant is a mixture of magnesium lauryl sulfate and magnesium stearate, 3 parts of magnesium lauryl sulfate and 3 parts of magnesium stearate.

Embodiment 2

[0021] This embodiment contains the pharmaceutical composition of trandolapril taste-masking composition, which is composed of the following raw materials in parts by weight: 60 parts of trandolapril taste-masking composition, pregelatinized starch 1500 filler 20 (4 parts of corn starch, 12 parts of potato starch and 4 parts of rice starch), 9 parts of polyvinylpyrrolidone binder, 8 parts of disintegrant and 6 parts of lubricant; wherein, the taste-masking composition of trandolapril consists of 20.13 Parts by weight of mannitol, 20.13 parts by weight of gelatin, 0.29 parts by weight of disodium glycyrrhizinate and 1.45 parts by weight of trandolapril are mixed; 5.04 parts of croscarmellose sodium and 2.96 parts of crospovidone; the lubricant is a mixture of magnesium lauryl sulfate and magnesium stearate, 3 parts of magnesium lauryl sulfate and 3 parts of magnesium stearate.

Embodiment 3

[0023] This embodiment contains the pharmaceutical composition of trandolapril taste-masking composition, which is composed of the following raw materials in parts by weight: 60 parts of trandolapril taste-masking composition, pregelatinized starch 1500 filler 20 (4 parts of corn starch, 12 parts of potato starch and 4 parts of rice starch), 9 parts of polyvinylpyrrolidone binder, 8 parts of disintegrant and 6 parts of lubricant; wherein, the taste-masking composition of trandolapril consists of 20.13 Parts by weight of mannitol, 20.13 parts by weight of gelatin, 0.29 parts by weight of disodium glycyrrhizinate and 1.45 parts by weight of trandolapril are mixed; 4.8 parts of croscarmellose sodium and 3.2 parts of crospovidone; the lubricant is a mixture of magnesium lauryl sulfate and magnesium stearate, 3 parts of magnesium lauryl sulfate and 3 parts of magnesium stearate.

[0024] The following table 1 is the mass ratio comparison table of croscarmellose sodium and crospovid...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a pharmaceutical composition containing a trandolapril taste masking composition. The pharmaceutical composition is prepared from, by weight, 60-80 parts of the trandolapril taste masking composition, 10-20 parts of filler, 5-9 parts of adhesive, 6-8 parts of disintegrant and 4-6 parts of lubricant, wherein the trandolapril taste masking composition is formed by mixing mannitol, gelatin, disodium glycyrrhizunate and trandolapril by the ratio of 20:20:0.1:1, and the disintegrant is a mixture of croscarmellose and polyvinylpolypyrrolidone by the mass ratio of (1.3-1.7):1. The pharmaceutical composition has the advantages of being capable of greatly improving the mouthfeel, and the disintegration speed of the pharmaceutical composition is increased.

Description

technical field [0001] The invention belongs to the field of medicines, in particular to a medicine containing trandolapril taste-masking composition [0002] with composition. Background technique [0003] Hypertension is defined as elevated arterial systolic and / or diastolic blood pressure at rest. Hypertension is a systemic disease characterized by elevated arterial pressure, which may be accompanied by functional or organic changes in the heart, blood vessels, brain, kidneys and other organs. It has primary hypertension and secondary hypertension points. There are many reasons for the onset of hypertension, which can be divided into two aspects: genetic and environmental. [0004] In addition, elevated blood pressure is also the fuse of many diseases, which will increase the risk of coronary heart disease, heart failure and kidney diseases. Since some hypertensive patients have no obvious clinical symptoms, hypertension is also known as the "invisible killer" of huma...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K38/05A61K9/20A61K47/42A61K47/26A61K47/10A61K47/36A61K47/32A61K47/20A61K47/12A61P9/12
CPCA61K9/2013A61K9/2018A61K9/2027A61K9/2059A61K9/2063A61K38/05
Inventor 肖方亮周宇张敏康毛建勇
Owner ABA CHEM SHANGHAI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap